Table 1.

Plasma CETP and (apo)lipoprotein levels in obese patients with type 2 diabetes mellitus and hepatic steatosis in response to 16 weeks of VLCD

Plasma parameters	Baseline	After VLCD	Δ (%)	P value
CETP (μg/mL)	2.48 ± 0.15	2.03 ± 0.14	−18.2	0.0021
Total cholesterol (mmol/L)	5.76 ± 0.30	5.00 ± 0.22	−13.1	0.0007
Triglycerides (mmol/L)	2.41 ± 0.28	1.32 ± 0.10	−45.1	0.0003
Phospholipids (mmol/L)	2.69 ± 0.11	2.28 ± 0.07	−15.2	0.0000
LDL-cholesterol (mmol/L)	3.99 ± 0.27	3.36 ± 0.20	−15.8	0.0028
ApoB100 (mg/dL)	130 ± 6	111 ± 5	−13.9	0.0016
HDL-cholesterol (mmol/L)	0.84 ± 0.04	0.91 ± 0.06	—	NS
HDL-phospholipids (mmol/L)	0.98 ± 0.03	0.98 ± 0.05	—	NS
ApoAI (mg/dL)	135 ± 10	156 ± 11	+16.2	0.0174

Data are presented as means ± SEM (n = 27). Δ values are calculated by comparing values obtained after VLCD with those obtained at baseline from obese patients with type 2 diabetes mellitus. P values are calculated using paired Student t test. NS, not significant.